143 related articles for article (PubMed ID: 25473651)
1. HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.
Meyer JP; Cepeda J; Springer SA; Wu J; Trestman RL; Altice FL
Lancet HIV; 2014 Nov; 1(2):e77-e84. PubMed ID: 25473651
[TBL] [Abstract][Full Text] [Related]
2. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
[TBL] [Abstract][Full Text] [Related]
3. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community.
Springer SA; Pesanti E; Hodges J; Macura T; Doros G; Altice FL
Clin Infect Dis; 2004 Jun; 38(12):1754-60. PubMed ID: 15227623
[TBL] [Abstract][Full Text] [Related]
5. Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study.
Loeliger KB; Altice FL; Desai MM; Ciarleglio MM; Gallagher C; Meyer JP
Lancet HIV; 2018 Feb; 5(2):e96-e106. PubMed ID: 29191440
[TBL] [Abstract][Full Text] [Related]
6. Predictors of reincarceration and disease progression among released HIV-infected inmates.
Baillargeon J; Giordano TP; Harzke AJ; Spaulding AC; Wu ZH; Grady JJ; Baillargeon G; Paar DP
AIDS Patient Care STDS; 2010 Jun; 24(6):389-94. PubMed ID: 20565323
[TBL] [Abstract][Full Text] [Related]
7. All-cause mortality among people with HIV released from an integrated system of jails and prisons in Connecticut, USA, 2007-14: a retrospective observational cohort study.
Loeliger KB; Altice FL; Ciarleglio MM; Rich KM; Chandra DK; Gallagher C; Desai MM; Meyer JP
Lancet HIV; 2018 Nov; 5(11):e617-e628. PubMed ID: 30197101
[TBL] [Abstract][Full Text] [Related]
8. Retention in HIV care during the 3 years following release from incarceration: A cohort study.
Loeliger KB; Meyer JP; Desai MM; Ciarleglio MM; Gallagher C; Altice FL
PLoS Med; 2018 Oct; 15(10):e1002667. PubMed ID: 30300351
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Immunologic and Virologic Function in Reincarcerated Patients Living With HIV or AIDS.
Badowski ME; Patel M
J Correct Health Care; 2022 Jun; 28(3):203-206. PubMed ID: 35447035
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.
Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC
MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322
[TBL] [Abstract][Full Text] [Related]
11. Association of Mental Health Services Access and Reincarceration Among Adults Released From Prison in British Columbia, Canada.
Palis H; Hu K; Rioux W; Korchinski M; Young P; Greiner L; Nicholls T; Slaunwhite A
JAMA Netw Open; 2022 Dec; 5(12):e2247146. PubMed ID: 36520435
[TBL] [Abstract][Full Text] [Related]
12. The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV.
Parchinski K; Di Paola A; Wilson AP; Springer SA
Drug Alcohol Depend Rep; 2023 Jun; 7():100159. PubMed ID: 37159815
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral treatment regimen outcomes among HIV-infected prisoners.
Springer SA; Friedland GH; Doros G; Pesanti E; Altice FL
HIV Clin Trials; 2007; 8(4):205-12. PubMed ID: 17720660
[TBL] [Abstract][Full Text] [Related]
14. Accessing antiretroviral therapy following release from prison.
Baillargeon J; Giordano TP; Rich JD; Wu ZH; Wells K; Pollock BH; Paar DP
JAMA; 2009 Feb; 301(8):848-57. PubMed ID: 19244192
[TBL] [Abstract][Full Text] [Related]
15. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
16. Hazardously Drinking Jailed Women: Post-Release Perceived Needs and Risk of Reincarceration.
Schonbrun YC; Johnson JE; Anderson BJ; Caviness C; Stein MD
Int J Offender Ther Comp Criminol; 2017 Dec; 61(16):1819-1832. PubMed ID: 26920551
[TBL] [Abstract][Full Text] [Related]
17. Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates.
Meyer JP; Cepeda J; Taxman FS; Altice FL
Am J Public Health; 2015 Sep; 105(9):1901-10. PubMed ID: 26180958
[TBL] [Abstract][Full Text] [Related]
18. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals.
Stephenson BL; Wohl DA; Golin CE; Tien HC; Stewart P; Kaplan AH
Public Health Rep; 2005; 120(1):84-8. PubMed ID: 15736336
[TBL] [Abstract][Full Text] [Related]
19. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.
Mussini C; Lorenzini P; Cozzi-Lepri A; Lapadula G; Marchetti G; Nicastri E; Cingolani A; Lichtner M; Antinori A; Gori A; d'Arminio Monforte A;
Lancet HIV; 2015 Mar; 2(3):e98-106. PubMed ID: 26424550
[TBL] [Abstract][Full Text] [Related]
20. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA;
Lancet HIV; 2015 Feb; 2(2):e42-51. PubMed ID: 26424460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
